$UTHR news
The latest UTHR stock news: headlines, filings, AI summaries and sentiment for $UTHR, updated around the clock.
- Liquidia Corporation Shares Rise 7% Following Q3 Results and Litigation Settlement
- Liquidia Reports Q3 2026 Growth Driven by YUTREPIA Sales and Legal Settlement
- MannKind Projects $1 Billion in Revenue from United Therapeutics Deal and Targets Q4 Profitability
- United Therapeutics Reports Record Q3 2026 Revenue Driven by Tyvaso Growth
- United Therapeutics Reports Q3 2026 Revenue Growth Amid Increased R&D Spending
- United Therapeutics Acquires Pfizer Royalty Interest in Experimental Lung Therapy Ralinepag
- UNITED THERAPEUTICS Corp - 8-K Filing
- UNITED THERAPEUTICS Corp - 10-Q Filing
- United Therapeutics Scheduled to Report Q3 2026 Earnings on November 4
- DPR Construction Appoints Scott Sass as Raleigh-Durham Business Unit Leader
- United Therapeutics Receives FDA Clearance for Phase 1 Trial of Treprostinil-Iloprost SMI
- UNITED THERAPEUTICS Corp - 8-K Filing
- Liquidia Reaches Settlement With United Therapeutics; Stock Rises Over 30%
- UNITED THERAPEUTICS Corp - 8-K Filing
- Liquidia Shares Rise Over 42% Following Settlement with United Therapeutics
- Wells Fargo Downgrades Liquidia Following Legal Setback
- Stocks Making Significant Moves Midday: Accenture, Synopsys, United Therapeutics, Vicor Among Others
- BTIG Downgrades Liquidia Stock to Neutral Amid Legal Setback
- Stocks Making Significant Moves Midday: Rogers Surges on Earnings Guidance; United Therapeutics and Moderna See Sharp Movements
- Liquidia Shares Drop Sharply After Court Ruling in Patent Dispute with United Therapeutics
- United Therapeutics and Sagimet Biosciences Shares Drop After Goldman Sachs Issues 'Sell' Ratings
- United Therapeutics Announces $477.6 Million Share Repurchase Amid Pipeline Funding Concerns
- UNITED THERAPEUTICS Corp - 8-K Filing
- FDA Accepts United Therapeutics' Application for Expanded Use of Nebulized Tyvaso
- Fundstrat Capital Completes August 2026 Rebalance for Granny Shots ETFs
- United Therapeutics Presents New Data for FDA Filings
- Fundstrat Granny Shots ETF Adds Allient and Others in Quarterly Portfolio Revision
- United Therapeutics CEO Sells $5 Million Worth of Shares
- United Therapeutics CEO Sells $5 Million Worth of Shares
- UNITED THERAPEUTICS Corp - 8-K Filing
- Liquidia Rises as Judge Criticizes United Therapeutics in Patent Dispute
- BETA Technologies Completes First eVTOL Integration Pilot Program Flights with Multistate Collaborative
- Beta Completes First Test Flights in U.S. Government’s Electric Air Taxi Pilot Program
- UNITED THERAPEUTICS Corp - 8-K Filing
- Renaissance Technologies' Top Holdings Include UTHR, PLTR, AAPL
- MannKind Corp Reports Q1 2026 Total Revenues of $90.2 Million
- MannKind Reports Q1 2026 Earnings with Revenue Growth and Key Product Updates
- United Therapeutics Q1 2026 Earnings Call Transcript Summary
- United Therapeutics Reports Q4 2025 Earnings with Revenue Growth and Pipeline Updates